Editorial Policies

Focus and Scope

EUREKA: Health Sciences covers the discipline of medical profile and applied disciplines focused on getting the finished product for medicine. Therefore, the authors in their materials should emphasize areas of application of their research, always emphasizing the ability to attract knowledge, aimed at preserving the health from related scientific fields.

The problems of the following areas:
- conventional western disciplines
- traditional and folk medicine,
- alternative medicine.

 

Section Policies

Medicine and Dentistry

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Nursing and Health Professions

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Pharmacology, Toxicology and Pharmaceutical Science

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Veterinary Science and Veterinary Medicine

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

The editorial board practices double-blind peer review.

 

Publication Frequency

The journal is published bimonthly.

Current number of the issue

1

2

3

4

5

6

Term of publication

31.01

31.03

31.05

31.07

30.09

30.11

The deadline for submission of articles to the corresponding issue of the journal

20.12

20.02

20.04

20.06

20.08

20.10

 

Open Access Policy

Journal "EUREKA: Health Sciences" is an open access journal. All articles are free for users to access, read, download, and print.

 

Archiving

This journal uses LOCKSS system for distributed archiving published content in multiple libraries and information centers. Library - project LOCKSS ensure long-term storage of comprehensive log files and automatically restoring damaged information.

 

Ethic norms of publication

Ethical Obligations of Editors 

1. All submitted materials are carefully selected and reviewed. An editorial board reserves the right to reject an article or return it as requiring improvement. The author is obliged to improve the article according to the remarks of the reviewers and the editorial board.

2. An editor should considerate all manuscripts offered for publication without prejudice, evaluating each on its merits without regard to race, religion, nationality, status, or institutional affiliation of the author(s). 3. An editor should consider manuscript submitted for publication without delays.

4. The whole responsibility for acceptance or rejection of an article rests with the editor. Responsible and reasonable approach to the duty requires that the editor seek advice from reviewers, Doctor of Science of required specialty, as to the quality and reliability of manuscripts submitted for publication. However, manuscripts may be rejected without external review if considered by the Editors to be inappropriate for the journal.

5. The editor and members of the editor’s staff should not disclose any information about a manuscript under consideration to anyone other than those from whom professional advice is sought. After a positive decision has been made about a manuscript, it should be published in the journal and in the website of the journal.

6. An editor should respect the intellectual independence of authors.

7. Editorial responsibility and authority for any manuscript authored by an editor and submitted to the editor’s journal should be delegated to other qualified person, such as a member of its Editorial Board.

8. If an editor is presented with convincing evidence that the main substance or conclusions of a report published in an editor’s journal are erroneous, the editor should facilitate publication of an appropriate report pointing out the error and, if possible, correcting it. The report may be written by the person who discovered the error or by an original author.

9. An author may request that the editor not use certain reviewers in consideration of a manuscript. However, the editor may decide to use one or more of these reviewers, if the editor feels their opinions are important in the fair consideration of a manuscript. This might be the case, for example, when a manuscript seriously disagrees with the previous work of a potential reviewer.

 

Ethical Obligations of Authors

1. Main duty of an author is to present an accurate account of the research performed as well as an objective discussion of its significance.

2. An author should be aware that journal space is a limited resource and should use it wisely and economically.

3. A primary research report should contain sufficient detail and reference to public sources of information to permit the author’s peers to repeat the work. When requested, the authors should make a reasonable effort to provide samples of unusual materials unavailable elsewhere, with appropriate material transfer agreements to restrict the field of use of the materials so as to protect the legitimate interests of the authors.

4. An author should cite those publications that have been influential in determining the nature of the reported work and that will guide the reader quickly to the earlier work that is essential for understanding the present investigation. Except in a review, citation of work that will not be referred to in the reported research should be minimized. An author is obligated to perform a literature search to find, and then cite, the original publications that describe closely related work. For critical materials used in the work, proper citation to sources should also be made when these were supplied by a non author.

5. Any unusual hazards appearing during an investigation should be clearly identified in a manuscript reporting the work.

6. Fragmentation of research reports should be avoided. A scientist who has done extensive work on a system or group of related systems should organize publication so that each report gives a well-rounded account of a particular aspect of the general study.

7. In submitting a manuscript for publication, an author should inform the editor of related manuscripts that the author has under editorial consideration or in press. Copies of those manuscripts should be supplied to the editor, and the relationships of such manuscripts to the one submitted should be indicated.

8. It is improper for an author to submit manuscripts describing essentially the same research to more than one journal of primary publication, unless it is a resubmission of a manuscript rejected for or withdrawn from publication. It is generally permissible to submit a manuscript for a full paper expanding on a previously published brief preliminary account (a “communication” or “letter”) of the same work. However, at the time of submission, the editor should be made aware of the earlier communication, and the preliminary communication should be cited in the manuscript.

9. An author should identify the source of all information quoted or offered, except that which is common knowledge. Information obtained privately, as in conversation, correspondence, or discussion with third parties, should not be used or reported in the author’s work without explicit permission from the investigator with whom the information originated. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, should be treated similarly.

10. An experimental or theoretical study may sometimes justify criticism, even severe criticism, of the work of another scientist. When appropriate, such criticism may be offered in published papers. However, in no case is personal criticism considered to be appropriate.

11. The co-authors of a paper should be all those persons who have made significant scientific contributions to the work reported and who share responsibility and accountability for the results. Other contributions should be indicated in a footnote or an “Acknowledgments” section. An administrative relationship to the investigation does not of itself qualify a person for co-authorship (but occasionally it may be appropriate to acknowledge major administrative assistance). Deceased persons who meet the criterion for inclusion as co-authors should be so included, with a footnote reporting date of death. No fictitious name should be listed as an author or coauthor. The author who submits a manuscript for publication accepts the responsibility of having included as co-authors all persons appropriate and none inappropriate. The submitting author should have sent each living co-author a draft copy of the manuscript and have obtained the co-author’s assent to co-authorship of it.

12. The authors should reveal to the editor and to the readers of the journal any potential and/or relevant competing financial or other interest that might be affected by publication of the results contained in the authors’ manuscript. All authors should not have any personal significant financial interest and employment or other relationship with entities that have a financial or other interest which can affect the results described by the manuscript.

 

Ethical Obligations of Reviewers of Manuscripts

1. As the reviewing of manuscripts is an essential step in the publication process, and therefore in the operation of the scientific method, every scientist has an obligation to do a fair share of reviewing.

2. A chosen reviewer who feels inadequately qualified to judge the research reported in a manuscript should return it promptly to the editor.

3. A reviewer of a manuscript should judge objectively the quality of the manuscript, of its experimental and theoretical work, of its interpretations and its exposition, with due regard to the maintenance of high scientific and literary standards. A reviewer should respect the intellectual independence of the authors.

4. A reviewer should be sensitive to the appearance of a conflict of interest when the manuscript under review is closely related to the reviewer’s work in progress or published. If in doubt, the reviewer should return the manuscript promptly without review, advising the editor of the conflict of interest.

5. A reviewer should not evaluate a manuscript authored or co-authored by a person with whom the reviewer has a personal or professional connection if the relationship would bias judgment of the manuscript.

6. A reviewer should treat a manuscript sent for review as a confidential document. It should neither be shown to nor discussed with others except, in special cases, to persons from whom specific advice may be sought; in that event, the identities of those consulted should be disclosed to the editor.

7. Reviewers should explain and support their judgments adequately so that editors and authors may understand the basis of their comments. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. Unsupported assertions by reviewers (or by authors in rebuttal) are of little value and should be avoided.

8. A reviewer should be alert to failure of authors to cite relevant work by other scientists, bearing in mind that complaints that the reviewer’s own research was insufficiently cited may seem self-serving. A reviewer should call to the editor’s attention any substantial similarity between the manuscript under consideration and any published paper or any manuscript submitted concurrently to another journal.

9. A reviewer should act promptly, submitting a report in a timely manner.

10. Reviewers should not use or disclose unpublished information, arguments, or interpretations contained in a manuscript under consideration, except with the consent of the author. If this information indicates that some of the reviewer’s work is unlikely to be profitable, the reviewer, however, could ethically discontinue the work.

 

Indexing

1. Index Copernicus Journals Master List is a scientific journal database that contain currently over 13,000 journals from all over the world. This database covers all fields of science. Registered journals undergo rigorous, multidimensional evaluation, proving high quality. Appreciation to the IC Journals Master List expressed the Ministry of Science and Higher Education of Poland by placing the database of scientific journals IC Journals Master List to the list of databases for indexing in which, periodicals receive additional points in the evaluation conducted by the Ministry (link)

2. CrossRef (included in 2016) is an association of scholarly publishers that develops shared infrastructure to support more effective scholarly communications. Our citation-linking network today covers over 68 million journal articles and other content items (books chapters, data, theses, technical reports) from thousands of scholarly and professional publishers around the globe (link)

3. Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines. Google Scholar index includes most peer-reviewed online academic journals and books, conference papers, theses and dissertations, preprints, abstracts, technical reports, and other scholarly literature, including court opinions and patents (link)

4. WorldCat - the world's largest bibliographic database, with over 240 million records of all kinds of products for 470 languages. Base is created by joint efforts of more than 72 thousand libraries in 170 countries across the organization Online Computer Library Center (link)

5. Directory of Open Access Journals (DOAJ) is website that lists open access journals and is maintained by Infrastructure Services for Open Access (IS4OA). The project defines open access journals as scientific and scholarly journals that meet high quality standards by exercising peer review or editorial quality control and "use a funding model that does not charge readers or their institutions for access" (link

6. International Institute of Organized Research (I2OR) has been established to promote various domains related to Education and Research around the globe to make it easily accessible and more organized (link)



7. 1findr – platform aiming to index articles in all peer-reviewed journals, in all fields of research, in all languages and from all over the world (link)




8. Ulrich's Periodicals Directory  - subscription catalog of American publishing Bowker, is the largest database that describes the global flow of periodicals in all subject areas (link)  


9. Neliti is a research repository that helps researchers and decision makers in Indonesia find research, data and evidence (link)

 

10. BASE - search engine, which is one of the most powerful suppliers of actual data on the scientific publications of European scientists (link)

11. ResearchBib - international multi-disciplinary database of scholarly journals, including a description of the log more than 5,400 publishers (link)

12. Eurasian Scientific Journal Index unites in its database the most important scientific journals in Europe and Asia, which publishes the most authoritative and relevant research (link)

13. Directory of Open Access scholarly Resources (ROAD) is a service offered by the ISSN International Centre with the support of the Communication and Information Sector of UNESCO (link

14. Scientific Indexing Services (SIS) – focuses on : citation indexing, citation analysis, and maintains citation databases covering thousands of academic journals. SIS Provides Quantitative And Qualitative Tool For Ranking, Evaluating And Categorizing The Journals For Academic Evaluation And Excellence (link)

SIS

 

15. Semantic Scholar is a project developed at the Allen Institute for Artificial Intelligence, it is designed to be an AI-backed search engine for scientific journal articles (link)

16. CORE (COnnecting REpositories) is aggregate all open access content distributed across different systems, such as repositories and open access journals, enrich this content using text mining and data mining, and provide free access to it through a set of services (link)


17. JournalTOCs is the largest, free collection of scholarly journal Tables of Contents (TOCs): is for researchers, students, librarians and anyone looking for the latest scholarly articles (link)

18. MIAR - Information Matrix for the Analysis of Journals. MIAR collects data for the identification and the analysis of scientific journals . If you enter an ISSN in the searchbox , the system will check in which databases, those referred to in the matrix, the jornal is indexed. The system holds more than 40,000 publications. It was founded in Barcelona, Spain (link)

 

19. WorldWideScience.org  is a global science gateway - accelerating scientific discovery and progress through a multilateral partnership to enable federated searching of national and international scientific databases and portals (link)

 
 
20. OpenAIRE is the European Research Information system that encompasses all research and enables ready-made reporting, monitoring and analysis. OpenAIRE link research outcomes (e.g., publications, data, software) to their creators (e.g., researchers, institutions, funders), enabling discoverability, transparency, reproducibility and quality-assurance of research (link)
21. Zeitschriftendatenbank (ZDB)  is one of the world’s largest databases for journals, newspapers, monographic series and other serial publications from all countries, in all languages, without time restrictions, in printed, electronic or digitised form (link)

22. Scilit is a comprehensive, free database for scientists using a new method to collate data and indexing scientific material. This database of scholarly works is developed and maintained by the open access publisher MDPI (link)

23. Dimensions  is a dynamic, easy to use, linked-research data platform that re-imagines the way research can be discovered, accessed and analyzed (link)

24. Socionet  is a data aggregator that forms a virtual scientific environment in the spirit of Open Science for creating and using information resources and services addressed to professional scientific communities (link)

25. Scholarly Citation Index Analytics (SCIA) provides transformative repository based library and indexing services, extended through external collaborations, that amplify the impact of research and basic literature based evaluations in developing research community (link)

26. Citefactor is a service that provides access to quality controlled Open Access Journals and proceedings, is world's largest indexing of scholarly journals & proceedings, which boost the worldwide visibility and accessibility of content (link)

width="225"


 

Conflict of interest statement

All manuscripts for types of articles that are submitted to the journal must be accompanied by a conflict of interest disclosure statement or a declaration by the authors that they do not have any conflicts of interest to declare. All articles that are published in the journal must be accompanied by this conflict of interest disclosure statement or a statement that the authors have replied that they have no conflicts of interest to declare. If a journal prints unsigned editorials, they should not have been written by anyone with a conflict of interest.

To facilitate this policy, all authors must privately disclose ‘ALL their potential conflicts of interest’ to the editors of the journal at the time of submission. These include all financial and non-financial interests and relationships, direct employment with a private sector entity (whether full or part-time), and service on private sector and non-profit Boards and advisory panels, whether paid or unpaid. Authors should also disclose any conflict of interest that may have influenced either the conduct or the presentation of the research to the editors, including but not limited to close relationships with those who might be helped or hurt by the publication, academic interests and rivalries, and any personal, religious or political convictions relevant to the topic at hand.

Authors may have strong views about the article being submitted for publication. The authors must consider disclosing these views and the editors may choose to print any affiliations or expressions from these views that may be relevant. These may be personal, political or intellectual, and may include any expression of strongly held views relevant to the subject of submission. Such disclosures may be original or they may be references to opinions previously expressed in books or monographs, opposite editorials or public comments, or to some prior sworn testimony or lobbying of legislators or legislative bodies. Disclosable non-financial conflicts of interest will also include membership or affiliation to non-governmental organizations that have an interest in the submission.

All reviewers that are reviewed manuscripts for the journal must accept by this conflict of interest disclosure statement or a statement that the reviewers have replied that they have no conflicts of interest to declare.

All editors that are worked with manuscripts for the journal must accept by this conflict of interest disclosure statement or a statement that the editors have replied that they have no conflicts of interest to declare.

 

 

Statement of Informed Consent

Consent to Participate in a Research Study

 

Title of Study:

 

Investigators:

Name:

 

Dept:

 

Phone:

 

Name:

 

Dept:

 

Phone:

 

Name:

 

Dept:

 

Phone:

 

       

 

[sample text in brackets]

Introduction

  • You are being asked to be in a research study of [insert general statement about study]. 
  • You were selected as a possible participant because [explain how subject was identified, include any exclusionary criteria]. 
  • We ask that you read this form and ask any questions that you may have before agreeing to be in the study.

 

Purpose of Study 

  • The purpose of the study is [explain research question and purpose in lay language].
  • Ultimately, this research may be [published as part of a book on…, presented as a paper, etc.]. 

 

Description of the Study Procedures

  • If you agree to be in this study, you will be asked to do the following things: [explain procedures and tasks; identify any procedures that are experimental; describe length of time for participation, frequency and duration of procedures; etc.] 

*[If applicable, explain any alternative procedures or courses of treatment available to the subject.]

 

Risks/Discomforts of Being in this Study

  • The study has the following risks.  First, [explain first risk, including the likelihood of the risk]. Second, [explain second risk, including the likelihood of the risk].  Third, …
  • [If there are no foreseeable risks, state as such] There are no reasonable foreseeable (or expected) risks.  There may be unknown risks.

 

Benefits of Being in the Study

  • The benefits of participation are [explain benefits of participation that will be gained by the participants and/or other. If a benefit is not likely to occur to each participant do not include
  • [If there are no expected benefits, state as such.]

 

Confidentiality [choose one of the following]

  • This study is anonymous.  We will not be collecting or retaining any information about your identity.
  • The records of this study will be kept strictly confidential. Research records will be kept in a locked file, and all electronic information will be coded and secured using a password protected file. [If audio or video tape recordings are made, explain specifically who will have access to them, if they will be used for educational purposes, and when they will be erased/destroyed and indicate how they will be destroyed or erased.]  We will not include any information in any report we may publish that would make it possible to identify you.
  • Your identity will be disclosed in the material that is published.  However, you will be given the opportunity to review and approve any material that is published about you.

 

Consent

  • Your signature below indicates that you have decided to volunteer as a research participant    for this study, and that you have read and understood the information provided above. You will be given a signed and dated copy of this form to keep, along with any other printed materials deemed necessary by the study investigators.   

 

Subject's Name (print):

 

 

 

Subject's Signature:

 

Date:

 

 

Investigator’s Signature:

 

Date:

 

 

 

Bioethics policy

Studies involving animals and humans 

For research manuscripts reporting experiments on living vertebrates and / or higher invertebrates, the correspondent author must confirm that all experiments were performed in accordance with the relevant guidelines and rules. The manuscript should include a statement indicating the institutional and / or licensing committee approving the experiments, including any relevant details. Gender and other characteristics of animals that may affect results should be described. Details of housing and livestock should be included if they can affect experimental results. All animal experiments must comply with ARRIVE guidelines and be conducted in accordance with the Great Britain Animal (Scientific Procedures) Act 1986 and related guidelines or EU Directive 2010/63/EU on the protection of animals used for scientific purposes [http://ec.europa.eu/ environment / chemicals / lab_animals / legislation_en.htm].

For a study in which people are participants, authors must identify a committee approving the study, ensure that the work has been carried out in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration) and include in your manuscript a statement confirming that informed consent was obtained from all participants (recommendations for obtaining informed consent).

You can also read the Helsinki Declaration in Russian on the website of the Association of Clinical Research Organizations

 

Clinical trial registration

Prospective clinical trials should be registered prior to the registration of patients on the website or in a similar public store (trials in which the main purpose is to determine pharmacokinetics are excluded.)

 

Human biological samples

To describe human biological samples, we recommend that you refer to the BRISQ reporting guidelines (reporting on biological samples to improve the quality of the study) and ensure that at least level 1 characteristics are provided (link).

 

Publication of images of participants in human subject research

When publishing identifiable images of study participants, authors should include a statement in the published article confirming that they have received informed consent to publish the images. All reasonable measures should be taken to protect the anonymity of the patient. Black stripes above the eyes are not an acceptable means of anonymization. In some cases, we may insist on obtaining evidence of the informed consent of the authors. Images without appropriate consent will be removed from the publication.

 

Studies involving human embryos, gametes, and stem cells

Manuscripts reporting experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, as well as the clinical use of stem cells, should include confirmation that all experiments have been performed in accordance with relevant guidelines and the rules.

The manuscript should include an ethical statement that identifies the institutional and / or licensing committees that approve the experiments and describe any relevant details. A statement of ethics should also confirm that informed consent has been obtained from all recipients and / or donors of cells or tissues, where necessary, and describe the conditions of donation of research materials, such as human embryos or gametes. The editors may request copies of approved and edited consent documents.

 

Experiments involving plants or microorganisms

Experiments with plants or microorganisms taken from outside the country of the authors should have been carried out with special permission.

 

Botanical identity. For each cultivated medicinal plant, its botanical identity must be established and documented - scientific name (variety, species, subspecies / variety, author and family). The common name (if any) must also be indicated in the local and English languages. If necessary, other relevant information should also be indicated, including the name of the cultivar, its ecotype, chemotype and phenotype.

For cultivated plant varieties available for sale, you must specify its name, as well as the supplier. In the case of collection, breeding, distribution and cultivation of landrace in a particular region, the line should be described with its local name, indicating the sources of origin of the seed, plant or sprout material.

Selection of medicinal plants. Where appropriate, the species or botanical species that are selected for cultivation should correspond to those indicated in the national pharmacopoeia or recommended by other authoritative national documents of the country of the final consumer. In the absence of such national documents, the selection of species or botanical varieties should be based on the pharmacopoeia or other authoritative documents of other countries. In the case when medicinal plants are considered for the first time, samples or botanical varieties selected for cultivation should be defined and documented as raw materials used or described in traditional medicine of the country of origin.

 

Experimental data

Analytical data should be statistically processed using appropriate programs.

When establishing the structure of substances, the authors must provide sufficient experimental information, in particular, the available 1H and 13C NMR spectra, and X-ray crystalline structural determinations are necessary for metal complexes.

The author is responsible for presenting the correct chemical nomenclature and terminology.

An accurate description of each data set should be provided, which is shown and should include the number of biological repeats, the number of experiments performed, and a description and use of appropriate statistical methods. To verify the significance of differences in results, appropriate statistical methods should be used. The term “significant” should not be used unless a statistical analysis has been performed and the probability value used to determine significance (usually p-value) should be indicated. Manuscripts submitted without evidence of reproducibility will be rejected without formal review.

 

Applications and additional materials 

Authors who wish to publish electronic supplementary materials to their article (Excel files, images, audio and video files) can send these files along with the manuscript.

 

Plagiarism and duplicate publication

Plagiarism is unacknowledged copying or an attempt to misattribute original authorship, whether of ideas, text or results. Plagiarism can be said to have clearly occurred when large chunks of text have been cut-and-pasted without appropriate and unambiguous attribution. Such manuscripts would not be considered for publication in journal «EUREKA: Health Sciences». "Text recycling" or reuse of parts of text from an author's previous research publication is a form of self-plagiarism.

Duplicate publication occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. This can range from publishing an identical paper in multiple journals, to only adding a small amount of new data to a previously published paper.

Journal «EUREKA: Health Sciences» editors assess all such cases on their individual merits. When plagiarism becomes evident post-publication, we may correct or retract the original publication depending on the degree of plagiarism, context within the published article and its impact on the overall integrity of the published study.

Material submitted to a «EUREKA: Health Sciences» journal must be original and not published or submitted for publication elsewhere. This rule applies to material submitted elsewhere while the «EUREKA: Health Sciences» journal contribution is under consideration.

All manuscripts submitted for consideration to the journal “EUREKA: Health Sciences” are checked for uniqueness by specialized service StrikePlagiarism.com. A manuscript can be accepted for consideration only if it is unique at least 80%.

Also, in addition, the uniqueness of the manuscript is evaluated at the stage of double-blind peer review (as one of the criteria that is evaluated by reviewers).

If the manuscript was also submitted for consideration in another journal, the authors are required to report this when submitting the manuscript to the journal “EUREKA: Health Sciences”.

 

Author fees

Publication fee is:

  • 100.00 Euro (publication of an article of 8-12 pages, designed according to the requirements for articles)
  • 150.00 Euro (publication of an article of 8-12 pages, designed according to the requirements for articles + printed copy of the journal)
  • the cost of one additional page, designed according to the requirements of the journal, is 5.00 Euro.

Journal doesn't have article submission charges